2024
Consensus and controversy in the management of paediatric and adult patients with ovarian immature teratoma: the Malignant Germ Cell International Consortium perspective
Pashankar F, Murray M, Gell J, MacDonald N, Shamash J, Billmire D, Klosterkemper L, Olson T, Hirsch M, Lockley M, Stoneham S, Frazier A. Consensus and controversy in the management of paediatric and adult patients with ovarian immature teratoma: the Malignant Germ Cell International Consortium perspective. EClinicalMedicine 2024, 69: 102453. PMID: 38544795, PMCID: PMC10965411, DOI: 10.1016/j.eclinm.2024.102453.Peer-Reviewed Original ResearchOvarian immature teratomaImmature teratomaElevated serum alpha-fetoproteinSurgery-only approachSerum alpha-fetoproteinOvarian ITStage IAAdjuvant chemotherapyRare neoplasmsOvarian cancerAdult patientsAlpha-fetoproteinLack of published dataPathologic interpretationPatient managementLow-gradeGrade 1Multiple subspecialtiesPatientsTeratomaYoung femalesAdult practiceNational advisory panelPaediatric teamGCT
2020
Liver transplantation in the treatment of unresectable hepatic metastasis from neuroendocrine tumors
Kim J, Zimmerman M, Hong J. Liver transplantation in the treatment of unresectable hepatic metastasis from neuroendocrine tumors. Journal Of Gastrointestinal Oncology 2020, 11: 601-608. PMID: 32655939, PMCID: PMC7340808, DOI: 10.21037/jgo.2019.11.03.Peer-Reviewed Original ResearchPost-OLT outcomesOrthotopic liver transplantationNeuroendocrine tumorsLiver metastasesLiver transplantationTreatment of unresectable hepatic metastasesPatients of neuroendocrine tumorsRecurrence-free patient survivalUnresectable hepatic metastasesPrediction of survival outcomesPrimary neuroendocrine tumorsUnresectable liver metastasesReview patient selection criteriaLiver neuroendocrine tumorsRate of recurrencePatient selection criteriaHepatic metastasesPrognostic factorsRare neoplasmsPost-OLTDefinitive treatmentMetastatic spreadSurvival outcomesPatient survivalMultiple tumors
2011
Acinar Cell Carcinoma of the Pancreas: New Genetic and Treatment Insights into a Rare Malignancy
Lowery M, Klimstra D, Shia J, Yu K, Allen P, Brennan M, O'Reilly E. Acinar Cell Carcinoma of the Pancreas: New Genetic and Treatment Insights into a Rare Malignancy. The Oncologist 2011, 16: 1714-1720. PMID: 22042785, PMCID: PMC3248770, DOI: 10.1634/theoncologist.2011-0231.Peer-Reviewed Original ResearchConceptsAcinar cell carcinomaOverall survivalCell carcinomaGermline mutationsMetastatic acinar cell carcinomaCase of acinar cell carcinomaPartial response to chemotherapyMemorial Sloan-Kettering Cancer CenterBRCA1 germline mutationsMedian overall survivalInstitutional review board approvalResponse to chemotherapyReview board approvalResectable diseaseStable diseaseSystemic chemotherapyRare malignancySystemic therapyRare neoplasmsMedian ageOS timePancreatic adenocarcinomaConsecutive casesPancreatic neoplasmsColorectal carcinomaLiver angiomyolipomas: A clinical, radiologic, and pathologic analysis of 22 patients from a single center
Butte J, K. R, Shia J, Gönen M, D’Angelica M, Getrajdman G, Allen P, Fong Y, DeMatteo R, Klimstra D, Jarnagin W. Liver angiomyolipomas: A clinical, radiologic, and pathologic analysis of 22 patients from a single center. Surgery 2011, 150: 557-567. PMID: 21621235, DOI: 10.1016/j.surg.2011.03.006.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAngiolipomaBiopsy, NeedleCohort StudiesCombined Modality TherapyContrast MediaDiagnostic ImagingFemaleFollow-Up StudiesHumansImmunohistochemistryLiver NeoplasmsMagnetic Resonance ImagingMaleMiddle AgedNeoplasm StagingRetrospective StudiesStatistics, NonparametricSurvival AnalysisTime FactorsTomography, X-Ray ComputedTreatment OutcomeConceptsClinical behaviorFollow-upPatients treated with R0 resectionMemorial Sloan-Kettering Cancer CenterLost to follow-upAssociated with disease-related mortalityIntra-arterial chemotherapyTreated with chemotherapyFree of diseaseSpectrum of presentationDisease-related mortalityLiver angiomyolipomasR0 resectionIndolent coursePatient diedConsecutive patientsRare neoplasmsAsymptomatic patientsHeterogeneous enhancementLiver involvementMedian ageUnrelated causeMesenchymal neoplasmsHistological featuresAngiomyolipoma
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply